Loading…

Aenova announces a major investment in its sterile manufacturing capabilities with the installation of another fill & finish line at its Latina site. The investment is approximately €100 million over three years, adding annual capacity of 30-40 million units. Construction is underway, equipment installation planned for 2026, and GMP manufacturing start in Q3 2027.
“The new fill & finish line will support a broad range of container formats, including vials ranging from 2R to 50R, pre-filled syringes from 0.5mL to 50mL, and pre-filled cartridges from 1mL to 20mL.”aenova-group.com
Summarized from public sources; check the original articles before acting on it.